In neurological applications, we perform intrathecal regenerative cell infusion, delivering the therapeutic cells directly into the cerebrospinal fluid under sterile conditions. This allows the regenerative factors to circulate around the brain and spinal cord, promoting neuroprotection, reducing inflammation, and improving cellular communication in conditions such as Parkinson’s disease, multiple sclerosis, autism spectrum disorder, and post-stroke recovery.
For systemic or autoimmune disorders, regenerative cells may be administered through intravenous infusion, targeting widespread inflammation and immune dysregulation. Patients with chronic fatigue, autoimmune arthritis, or metabolic syndromes often benefit from improved vitality and reduced inflammatory markers after therapy.
Each procedure is performed by anesthesiologists and neurologists specialized in regenerative protocols, ensuring maximum safety and precision. All cells are processed under GMP standards and undergo multi-level quality verification before administration, reflecting WIH’s commitment to excellence in modern regenerative medicine.